Barclays’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$533K	Buy	57,334 +37,063	+183%	+$345K	﹤0.01%	3010
2025 Q1	$264K	Sell	20,271 -9,836	-33%	-$128K	﹤0.01%	3190
2024 Q4	$524K	Buy	30,107 +20,107	+201%	+$350K	﹤0.01%	3025
2024 Q3	$255K	Buy	+10,000	New	+$255K	﹤0.01%	3368